1. Home
  2. MORN vs HALO Comparison

MORN vs HALO Comparison

Compare MORN & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Morningstar Inc.

MORN

Morningstar Inc.

HOLD

Current Price

$216.21

Market Cap

9.0B

Sector

Finance

ML Signal

HOLD

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

HOLD

Current Price

$70.69

Market Cap

7.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MORN
HALO
Founded
1984
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.0B
7.6B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
MORN
HALO
Price
$216.21
$70.69
Analyst Decision
Strong Buy
Buy
Analyst Count
3
12
Target Price
$333.33
$73.33
AVG Volume (30 Days)
359.2K
2.6M
Earning Date
10-29-2025
11-03-2025
Dividend Yield
0.85%
N/A
EPS Growth
16.18
56.68
EPS
8.80
4.74
Revenue
$2,395,400,000.00
$1,242,852,000.00
Revenue This Year
$8.52
$32.47
Revenue Next Year
$7.45
$24.31
P/E Ratio
$24.47
$15.08
Revenue Growth
7.76
31.19
52 Week Low
$202.89
$46.26
52 Week High
$365.00
$79.50

Technical Indicators

Market Signals
Indicator
MORN
HALO
Relative Strength Index (RSI) 49.68 54.18
Support Level $205.97 $68.09
Resistance Level $215.23 $74.25
Average True Range (ATR) 4.04 2.25
MACD 1.07 0.28
Stochastic Oscillator 76.89 50.26

Price Performance

Historical Comparison
MORN
HALO

About MORN Morningstar Inc.

Morningstar Inc is a provider of independent investment research to financial advisers, asset managers, and investors. The company focuses its operations on two core sectors: data and research. It offers data on investments such as mutual funds, stocks, exchange-traded funds, closed-end funds, separate accounts, and variable annuities. Further, the company tracks real-time market data of equity, derivative, currency exchanges, and other investments. In its research operation, Morningstar offers analyst research on passive and active mutual funds, alternative funds, and college saving plans. Morningstar's majority of the revenue is generated in the United States of America.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: